Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Renal Cell 30Neoplasms 11Sarcoma 8Carcinoma, Non-Small-Cell Lung 8Breast Neoplasms 7Ovarian Neoplasms 6Neoplasm Metastasis 5Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Recurrence 2Hemangiosarcoma 2Financial Stress 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Ovarian Epithelial 2Uterine Diseases 1Uterine Cervical Neoplasms 1Uterine Cervical Diseases 1Solid Tumours 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Prostatic Neoplasms 1Patient Preference 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplasms, Plasma Cell 1Melanoma 1Liver Neoplasms 1Leiomyosarcoma 1

Interventions

Doxorubicin 5Dacarbazine 5Trabectedin 3belinostat 2PTC596 2toripalimab 1soblidotin 1rucaparib 1ridaforolimus 1reolysin 1pembrolizumab 1pazopanib 1olaratumab 1futibatinib 1cixutumumab 1cemiplimab 1anlotinib 1Tablets 1TTI-621 1Rosuvastatin Calcium 1PM 01183 1Midazolam 1Injections 1Imatinib Mesylate 1Ifosfamide 1Fluorouracil 1Erlotinib Hydrochloride 1Docetaxel 1Digoxin 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Leiomyosarcoma × pazopanib × Clear all
NCT00297258 2016-02-03

Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma

GlaxoSmithKline

Phase 2 Completed
148 enrolled 8 charts
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡